Clinical trial supply chain design based on the Pareto-optimal trade-off between time and cost

ABSTRACT Long duration and high cost are two key characteristics of clinical trials. Since the clinical trial duration is part of the limited patent life and determines the time to market, its reduction is of critical importance. Although the duration can be reduced through increasing the number of clinical sites in the supply chain, the total enrollment and operational costs are also increased. Hence, Pareto-optimal supply chain configurations are used to improve clinical trial efficiency. In this study, we propose a multi-objective clinical site selection model that considers the trade-off between time and cost of clinical trials. An efficiency curve representing the Pareto-optimal trade-off is provided for decision makers to design the supply chain. To identify all Pareto-optimal supply chain configurations efficiently, we develop an algorithm based on proposed propositions. The optimality cuts are derived to improve the solving efficiency of this problem.

[1]  David W. Coit,et al.  Multi-objective optimization using genetic algorithms: A tutorial , 2006, Reliab. Eng. Syst. Saf..

[2]  C. A. Coello Coello,et al.  A Comprehensive Survey of Evolutionary-Based Multiobjective Optimization Techniques , 1999, Knowledge and Information Systems.

[3]  Marc Goetschalckx,et al.  A stochastic programming approach for supply chain network design under uncertainty , 2004, Eur. J. Oper. Res..

[4]  J. B. G. Frenk,et al.  Heuristic for the 0-1 Min-Knapsack Problem , 1991, Acta Cybern..

[5]  Mark Goh,et al.  Production , Manufacturing and Logistics A stochastic model for risk management in global supply chain networks , 2007 .

[6]  T. Drezner,et al.  Competitive supply chain network design: An overview of classifications, models, solution techniques and applications , 2014 .

[7]  Sai Ho Chung,et al.  A multi-criterion genetic algorithm for order distribution in a demand driven supply chain , 2004, Int. J. Comput. Integr. Manuf..

[8]  Ignacio E. Grossmann,et al.  Optimization Models for the Scheduling of Testing Tasks in New Product Development , 1996 .

[9]  Reza Zanjirani Farahani,et al.  A genetic algorithm to optimize the total cost and service level for just-in-time distribution in a supply chain , 2008 .

[10]  Stefan Nickel,et al.  A multi-stage stochastic supply network design problem with financial decisions and risk management , 2012 .

[11]  Mehrdad Tamiz,et al.  Multi-objective meta-heuristics: An overview of the current state-of-the-art , 2002, Eur. J. Oper. Res..

[12]  Hui Quan,et al.  Sample Size Calculation for Count Data in Comparative Clinical Trials with Nonuniform Patient Accrual and Early Dropout , 2015, Journal of biopharmaceutical statistics.

[13]  Eleni Hadjiconstantinou,et al.  A new path-based cutting plane approach for the discrete time-cost tradeoff problem , 2010, Comput. Manag. Sci..

[14]  B. Beamon.  Supply chain design and analysis:: Models and methods , 1998 .

[15]  Turan Paksoy,et al.  A genetic algorithm approach for multi-objective optimization of supply chain networks , 2006, Comput. Ind. Eng..

[16]  Jennifer Gonzalez.  The Pharmaceutical Research and Manufacturers of America , 2005 .

[17]  Kai Huang,et al.  The Value of Multistage Stochastic Programming in Capacity Planning Under Uncertainty , 2009, Oper. Res..

[18]  I ScottKirkpatrick.  Optimization by Simulated Annealing: Quantitative Studies , 1984 .

[19]  Terry P. Harrison,et al.  Global Supply Chain Management at Digital Equipment Corporation , 1995 .

[20]  Shabbir Ahmed,et al.  A Multi-Stage Stochastic Integer Programming Approach for Capacity Expansion under Uncertainty , 2003, J. Glob. Optim..

[21]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[22]  Gintaras V. Reklaitis,et al.  Simulation-optimization approach to clinical trial supply chain management with demand scenario forecast , 2012, Comput. Chem. Eng..

[23]  Seyed Taghi Akhavan Niaki,et al.  A multi-objective facility location model with batch arrivals: two parameter-tuned meta-heuristic algorithms , 2013, J. Intell. Manuf..

[24]  Alexander Shapiro,et al.  Lectures on Stochastic Programming: Modeling and Theory , 2009 .

[25]  Gordon H. Huang,et al.  An interval-parameter multi-stage stochastic programming model for water resources management under uncertainty , 2006 .

[26]  Adam J. Fleischhacker,et al.  Positioning Inventory in Clinical Trial Supply Chains , 2015 .

[27]  Thomas J Lynch,et al.  The phase III trial in the era of targeted therapy: unraveling the "go or no go" decision. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Paul I. Barton,et al.  Capacity Planning under Clinical Trials Uncertainty in Continuous Pharmaceutical Manufacturing, 1: Mathematical Framework , 2012 .

[29]  Hande Yaman,et al.  A multi-stage stochastic programming approach in master production scheduling , 2011, Eur. J. Oper. Res..

[30]  Alexander Shapiro,et al.  The Sample Average Approximation Method Applied to Stochastic Routing Problems: A Computational Study , 2003, Comput. Optim. Appl..

[31]  Francisco Saldanha-da-Gama,et al.  Facility location and supply chain management - A review , 2009, Eur. J. Oper. Res..

[32]  Amr K. Mortagy,et al.  A multi-objective model for locating fire stations , 1998, Eur. J. Oper. Res..

[33]  Ignacio E. Grossmann,et al.  Optimal resource investment and scheduling of tests for new product development , 2004, Comput. Chem. Eng..

[34]  Fengqi You,et al.  Design under uncertainty of hydrocarbon biorefinery supply chains: Multiobjective stochastic programming models, decomposition algorithm, and a Comparison between CVaR and downside risk , 2012 .

[35]  Shabbir Ahmed,et al.  Supply chain design under uncertainty using sample average approximation and dual decomposition , 2009, Eur. J. Oper. Res..

[36]  Lotfi A. Zadeh,et al.  Optimality and non-scalar-valued performance criteria , 1963 .

[37]  Anthony Clemento.  New and Integrated Approaches to Successful Accelerated Drug Development , 1999 .

[38]  Christos T. Maravelias,et al.  Modeling methods and a branch and cut algorithm for pharmaceutical clinical trial planning using stochastic programming , 2010, Eur. J. Oper. Res..

[39]  H. Badri,et al.  A two-stage stochastic programming approach for value-based closed-loop supply chain network design , 2017 .

[40]  R. K. Ursem.  Multi-objective Optimization using Evolutionary Algorithms , 2009 .

[41]  Rick Mullin.  BEFORE THE STORM: A near record high in NEW DRUG APPROVALS fortifies the pharmaceutical industry ahead of next year’s patent expiries , 2011 .

[42]  Ignacio E. Grossmann,et al.  Logic Inference and a Decomposition Algorithm for the Resource-Constrained Scheduling of Testing Tasks in the Development of New Pharmaceutical and Agrochemical Products , 2006 .

[43]  Alexander Shapiro,et al.  The Sample Average Approximation Method for Stochastic Discrete Optimization , 2002, SIAM J. Optim..

[44]  J.M. Laínez,et al.  Challenges and opportunities in enterprise-wide optimization in the pharmaceutical industry , 2012, Comput. Chem. Eng..

[45]  Adel Guitouni,et al.  Multi-objectives Tabu Search based algorithm for progressive resource allocation , 2007, Eur. J. Oper. Res..

[46]  R. Marler,et al.  The weighted sum method for multi-objective optimization: new insights , 2010 .

[47]  João C. N. Clímaco,et al.  Capacitated single allocation hub location problem - A bi-criteria approach , 2008, Comput. Oper. Res..

[48]  Gong Tang,et al.  Prediction of accrual closure date in multi-center clinical trials with discrete-time Poisson process models. , 2012, Pharmaceutical statistics.

[49]  Christos T. Maravelias,et al.  A stochastic programming approach for clinical trial planning in new drug development , 2008, Comput. Chem. Eng..

[50]  Nilay Shah,et al.  Pharmaceutical supply chains: key issues and strategies for optimisation , 2004, Comput. Chem. Eng..

[51]  Nikolaos V. Sahinidis,et al.  Optimization under uncertainty: state-of-the-art and opportunities , 2004, Comput. Chem. Eng..

[52]  Masoumeh Kazemi Zanjani,et al.  A multi-stage stochastic programming approach for production planning with uncertainty in the quality of raw materials and demand , 2010 .

[53]  Kathleen B Drennan,et al.  Patient recruitment: the costly and growing bottleneck in drug development. , 2002, Drug discovery today.

[54]  M.A. El-Sharkawi,et al.  Pareto Multi Objective Optimization , 2005, Proceedings of the 13th International Conference on, Intelligent Systems Application to Power Systems.

[55]  Reza Tavakkoli-Moghaddam,et al.  A new multi-objective stochastic model for a forward/reverse logistic network design with responsiveness and quality level , 2013 .

[56]  Christos T. Maravelias,et al.  Scheduling of testing tasks and resource planning in new product development using stochastic programming , 2009, Comput. Chem. Eng..

[57]  G GaticaDiazEscobar.  Capacity planning under clinical trials uncertainty. , 2004 .

[58]  J. Eisenberg,et al.  Study protocol: a randomized clinical trial of total parenteral nutrition in malnourished surgical patients. , 1988, The American journal of clinical nutrition.

[59]  Gloria Pérez,et al.  An Approach for Strategic Supply Chain Planning under Uncertainty based on Stochastic 0-1 Programming , 2003, J. Glob. Optim..

[60]  Vipul Jain,et al.  Resource-Constrained Scheduling of Tests in New Product Development , 1999 .

[61]  Yue Wu,et al.  Single and multi-period optimal inventory control models with risk-averse constraints , 2009, Eur. J. Oper. Res..

[62]  Seungjae Lee,et al.  Stochastic multi-objective models for network design problem , 2010, Expert Syst. Appl..

[63]  Scott Kirkpatrick,et al.  Optimization by simulated annealing: Quantitative studies , 1984 .

[64]  Adam J. Fleischhacker.  AN INVESTIGATION OF CLINICAL TRIAL SUPPLY CHAINS , 2009 .

[65]  Gautam Mitra,et al.  Computational solution of capacity planning models under uncertainty , 2000, Parallel Comput..

[66]  J. DiMasi,et al.  Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009 , 2011, Clinical pharmacology and therapeutics.

[67]  Kenneth A. Getz,et al.  Breaking the Development Speed Barrier: Assessing Successful Practices of the Fastest Drug Development Companies , 2000 .

[68]  Kalyanmoy Deb,et al.  Multi-objective Genetic Algorithms: Problem Difficulties and Construction of Test Problems , 1999, Evolutionary Computation.

[69]  Anthony J. Sinskey,et al.  Trends in the globalization of clinical trials , 2008, Nature Reviews Drug Discovery.

[70]  Eleni Hadjiconstantinou,et al.  The Stochastic Discrete Time-Cost Tradeoff Problem with Decision-Dependent Uncertainty , 2015 .